The August 20, 2015, edition of MDDI DeviceTalk features an exclusive guest blog by StarFish Medical Mechanical Engineer, Nigel Syrotuck. Is 23andMe the New Medical Device Paradigm? examines 23andMe, a saliva-based DNA service that provides genetic reports on ancestry, family history and helps clients connect with DNA relatives.
Nigel discusses 23andMe’s announcement on raising $79M to pivot their business to drug development as evidence of a new business model that completes their traditionally backwards strategy of marketing to the masses first, then health care providers later. He includes an outline for “wellness first” business model.